NAUT News and Press, Nautilus Biotechnology Inc. From 08/05/21

Shares of Nautilus Biotechnology (NAUT +50.6%) are surging in afternoon trading following a CNBC report that Amazon (AMZN +0.6%) held a ~$15M stake in the company at the end of Q2. The disclosure of the $14.7M investment was made in a recent Amazon SEC Form 13F filing. Nautilus just went publ...

ermess/iStock via Getty Images Jefferies has initiated shares of Nautilus ([[NAUT]] -0.4%) with a buy rating and $13 price target (~30% upside) as the early-stage life sciences tools company's platform focuses on analyzing the human proteome. Analyst Brandon Couillard writes that the company'...

SEATTLE, July 13, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the second quarter of...

Proteomics has the potential to revolutionize medicine in potentially the same way that genomics has. The traditional field looks primed for disruption and that effort could hit critical mass soon. Quantum-Si has set forth a business plan to utilize consumables as the primary driver o...

SEATTLE, June 17, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the appointment of Emma Lundberg, Ph.D. to its Scientific Advis...